Dengie Crops Limited – Trademark Portfolio
Entity Type: 03
Dengie Crops Limited holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DENGIE. The owner is based in Asheldham, Southminster, Essex CM0 7JF.
Hall Road
Asheldham, Southminster, Essex CM0 7JF , GB
Showing of trademarks Trademarks
Trademark Classifications
Dengie Crops Limited's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Dengie Crops Limited have?
Dengie Crops Limited has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 5 cancelled.
What trademark classes does Dengie Crops Limited file in?
Dengie Crops Limited files trademarks across 3 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are Dengie Crops Limited's most well-known trademarks?
Dengie Crops Limited's registered trademark portfolio includes well-known marks such as DENGIE. These are among 1 currently registered trademark in the portfolio.
What is Dengie Crops Limited's trademark registration success rate?
Dengie Crops Limited has a 13% trademark registration rate, with 1 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.